<DOC>
	<DOCNO>NCT02680379</DOCNO>
	<brief_summary>The purpose study determine whether Lovastatin , Minocycline combination Lovastatin/Minocycline effective treat behavioral symptom Fragile X individual .</brief_summary>
	<brief_title>Combined Treatment Minocycline Lovastatin Treat Individuals With Fragile X Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fragile X Syndrome</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Lovastatin</mesh_term>
	<mesh_term>L 647318</mesh_term>
	<mesh_term>Dihydromevinolin</mesh_term>
	<criteria>Must molecular diagnosis fragile X syndrome The participant must accompany sponsor may person parental authority , tutor ( minor ) representative ( major inapt ) Identify caregiver spends least six hour per day participant . The sponsor caregiver may person Intelligence quotient ( IQ ) &lt; 70 ABCC &gt; 20 CGIS â‰¥ 4 Pregnant breastfeeding subject Intolerance / allergy previous statin , minocycline tetracycline Taking lovastatin take minocycline last 12 week Personal history myopathy , myalgia high creatine kinase ( CK ) level Renal disease / liver / hepatorenal balance disturb , antinuclear antibody ( ANA ) &gt; 40 Concomitant use prohibit drug * Taking two psychoactive medication except anticonvulsant Untreated hypothyroidism / uncontrolled Any active medical condition Amendment psychoactive treatment last 6 week prior randomization * Prohibited drug include hypolipemic include gemfibrozil ( fibrates ) niacin ( nicotinic acid ) , angiotensin convert enzyme ( ACE ) , cyclosporine , danazol , amiodarone , verapamil inhibitor P450 ( CYP3A4 ) ( itraconazole , ketoconazole , erythromycin , clarithromycin , telithromycin , inhibitor HIV protease nefazodone ) .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Fragile X Syndrome</keyword>
	<keyword>Autism</keyword>
	<keyword>FMR1</keyword>
	<keyword>FRAXA</keyword>
</DOC>